ArticleDrug design, development and therapy2020

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.

Mohammad M Al-Sanea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.